Last reviewed · How we verify

NCT03782740

Effect of Melatonin on Reduction of Pelvic Pain

Completed Phase 2 Last updated 5 April 2022
What this trial tests

Phase 2 trial testing Melatonin 10 mg in Dysmenorrhea in 80 participants. Completed in 30 June 2021.

Timeline
15 March 2019
Primary endpoint
27 June 2021
30 June 2021

Quick facts

Lead sponsorKarolinska Institutet
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment80
Start date15 March 2019
Primary completion27 June 2021
Estimated completion30 June 2021
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 55, female only, with Dysmenorrhea or Endometriosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In two double blinded randomized controlled trials (RCT) we will study the effect of pain reduction of melatonin vs placebo in women with severe dysmenorrhea and women with endometriosis.The aim is to find an effective method for pelvic pain caused by dysmenorrhea and endometriosis.The primary outcome is reduction of pain in patients with dysmenorrhea and endometriosis respectively when treated with melatonin vs placebo. Secondary outcomes include the effect on daily life, quality of life and cognition. Sleep will also be assessed to evaluate its potential relation to quality of life and cognition.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review.
    Hung SW, Zhang R, Tan Z, Chung JPW, et al · · 2021 · cited 120× · PMID 33948974 · DOI 10.1002/med.21802
  2. Endometriosis and pain in the adolescent- striking early to limit suffering: A narrative review.
    Sieberg CB, Lunde CE, Borsook D. · · 2020 · cited 29× · PMID 31862211 · DOI 10.1016/j.neubiorev.2019.12.004
  3. Adjuvant use of melatonin for pain management in endometriosis-associated pelvic pain-A randomized double-blinded, placebo-controlled trial.
    Söderman L, Böttiger Y, Edlund M, Järnbert-Pettersson H, et al · · 2023 · cited 13× · PMID 37267394 · DOI 10.1371/journal.pone.0286182
  4. Adjuvant use of melatonin for pain management in dysmenorrhea - a randomized double-blinded, placebo-controlled trial.
    Söderman L, Edlund M, Böttiger Y, Marions L. · · 2022 · cited 12× · PMID 34668986 · DOI 10.1007/s00228-021-03234-6
  5. The Hallmarks of Endometriosis.
    Psilopatis I, Burghaus S, Au K, Hofbeck L, et al · · 2024 · cited 6× · PMID 38884026 · DOI 10.1055/a-2306-8759

Verify or expand the search:

Other trials of Melatonin 10 mg

Trials testing the same drug.

Other recruiting trials for Dysmenorrhea

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03782740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing